Sopherion Therapeutics Company
Sopherion has the US and Canadian rights to this liposomal nanotechnology that targets the tumor vasculature.
Headquarters:
East Brunswick, New Jersey, United States
Technology:
Biologics
Estimated Revenue:
$10M to $50M
Founded Date:
2001
Industry:
PharmTech